MedTrace Logo

Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China

NCT06546202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1271

Last updated 2025-07-23

No results posted yet for this study

Summary

The aim of this study is to investigate the pharmacological treatment pattern among patients with diabetic peripheral neuropathic pain (DPNP) and chemotherapy-induced peripheral neuropathy (CIPN) in China.

Conditions

  • Diabetic Peripheral Neuropathic Pain
  • Chemotherapy-induced Peripheral Neuropathy
  • Neuropathic Pain

Interventions

OTHER

No Drug

This is an non-interventional, observational study. No drug was administered during this study.

Sponsors & Collaborators

  • Daiichi Sankyo Co., Ltd.

    collaborator INDUSTRY

  • Daiichi Sankyo

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-16
Primary Completion
2025-07-18
Completion
2025-07-18

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546202 on ClinicalTrials.gov